Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Alexander Tchourbanov
    Member
    • Sep 2009
    • 10

    GFF3 display in IGV

    Dear colleagues,

    I am trying to display the variants annotations along with predictions of exonic aberrant isoforms in IGV and can't make it to display color. Moreover, only gene field in the GFF3 last description column is actually used for display, which I would like to replace with the field like note=... Is there way to make it better (I though using track description may help but so far it didn't)?

    Code:
    ##gff-version 3
    #track name="Aberrant splicing" color=FF0000 gffTags=on
    chr10	varclass	splicingVariants	100018766	100018821	.	-	.	Var=0.1->0.07;gene=Overlapping exon change (0.1->0.07);ref=novel;InRegion;color=FF0000
    chr10	varclass	splicingVariants	100018844	100018844	.	+	.	Var=G->A;gene=G->A;ref=novel;InRegion;color=FF0000
    chr10	varclass	splicingVariants	100018766	100018832	.	-	.	Var=0.07;gene=Exon compromising is created (0.07);ref=novel;InRegion;color=FF0000
  • Jim Robinson
    Member
    • May 2009
    • 75

    #2
    Hi,

    First IGV has a help forum where you are more likely to get a timely response, the URL is https://groups.google.com/forum/?hl=...forum/igv-help

    A couple of points (1) you don't need the "gffTags" in your track line, that is for using gff tags in bed files (2) your color strings need a if you use a hex number, for example #FF0000. I'm not sure what you mean by "used for display", its used to label the feature but if you mouse over it you will see all the attributes. I assume you are using IGV 2.0 or 2.1.

    -- Jim

    Comment

    • Alexander Tchourbanov
      Member
      • Sep 2009
      • 10

      #3
      Thanks for the good hint regarding use of # before color code, it works! The working link to IGV group discussion is http://groups.google.com/group/igv-help/.

      At the GFF3 display page for IGV browser

      we have the following recommended format

      Code:
      ##gff-version 3
      chr1 varclass variants_454HCDiffs 59133 59133 33 . . Var=A->G;AA=S->S;depth=9;frame=+1;gene=OR4F5;ref=novel;InRegion;color=0000EE
      chr1 varclass variants_454HCDiffs 59374 59374 67 . . Var=A->G;AA=T->A;depth=30;frame=+1;gene=OR4F5;ref=rs2691305;InRegion;color=EE0000
      chr1 varclass variants_454HCDiffs 731442 731442 100 . . Var=T->C;AA=->;depth=3;frame=;gene=;ref=rs3115865,rs61770168;OutOfRegion;color=AAAAAA
      That is why I made this mistake. By display I mean that only gene=G->A is displayed as label underneath a glyph (but this is not a gene annotation). I wish I could have more flexible way of annotating my glyphs, but at this point I don't have a clue how to accomplish it.
      Last edited by Alexander Tchourbanov; 02-15-2012, 04:14 AM.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      210 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      78 views
      0 reactions
      Last Post SEQadmin2  
      Working...